Results 151 to 160 of about 568,291 (208)

Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE. [PDF]

Sci Rep
Huo L, Naveen Kumar A, Tumurkhuu G, Bose M, Berman DS, Wallace DJ, Wei J, Ishimori M, Bairey Merz CN, Jefferies C.   +9 more
europepmc   +1 more source

Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond. [PDF]

J Mol Cell Cardiol
McCallinhart PE, Chade AR, Bender SB, Trask AJ.   +3 more
europepmc   +1 more source

Prognostic role of con-/discordant coronary flow reserve and microvascular resistance in coronary microvascular disease: a systematic review and network meta-analysis. [PDF]

Open Heart
Al-Gully J, Oliveri F, Forouzanfar JP, Montero-Cabezas JM, Jukema JW, den Haan MC, Al Amri I, Bingen BO.   +7 more
europepmc   +1 more source

Adipose stromal vascular fraction reverses mitochondrial dysfunction and hyperfission in aging-induced coronary microvascular disease.

Am J Physiol Heart Circ Physiol, 2022
Tracy EP, Nair R, Rowe G, Beare JE, Beyer A, LeBlanc AJ.   +5 more
europepmc   +1 more source

eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes. [PDF]

Diabetologia
Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, Watanabe M, Tsuji-Hosokawa A, Zheng Q, Yang M, Razan MR, Kempf CL, Camp SM, Wang J, Garcia JGN, Makino A.   +13 more
europepmc   +1 more source

Coronary Sinus Reducer Improves Myocardial Perfusion in a Patient With Angina, Hypertrophic Cardiomyopathy, and Coronary Microvascular Disease. [PDF]

CJC Open
Hoole SP, Tweed K, Williams L, Weir-McCall J.   +3 more
europepmc   +1 more source

Efficacy and safety of Tongxin formula in the treatment of coronary microvascular disease: A randomized, double-blind, placebo-controlled clinical trial study. [PDF]

Heliyon
Xie FQ, Wang YS, Zhang L, Zhu W, Cheng J, Lu YY, Xu SH, Li XK, Feng QM.   +8 more
europepmc   +1 more source

Multimodality assessment of the coronary microvasculature with TIMI frame count versus perfusion PET highlights coronary changes characteristic of coronary microvascular disease. [PDF]

Front Cardiovasc Med
Wayne N, Wu Q, Moore SC, Ferrari VA, Metzler SD, Guerraty MA.   +5 more
europepmc   +1 more source

[Coronary microvascular changes in Chagas' disease].

Arquivos brasileiros de cardiologia, 1996
M A, Rossi, S G, Ramos
openaire   +1 more source